Vedolizumab versus ustekinumab in Crohn's disease with prior anti-tumor necrosis factor failure: an updated meta-analysis. Milioli NJ, Fernandes MV, Correa TL, Antunes V, et al. Eur J Gastroenterol Hepatol 2024 Jul 2. doi: 10.1097/MEG.0000000000002817.

Read + Share

Amedeo Smart

Independent Medical Education

Milioli NJ, Fernandes MV, Correa TL, Antunes V, et al. Vedolizumab versus ustekinumab in Crohn's disease with prior anti-tumor necrosis factor failure: an updated meta-analysis. Eur J Gastroenterol Hepatol 2024 Jul 2. doi: 10.1097/MEG.0000000000002817.
PMID: 38973525